LANA Binds to Multiple Active Viral and Cellular Promoters and Associates with the H3K4Methyltransferase hSET1 Complex

PLoS Pathogens

Volumn 10, Issue 7, 2014, Pages

  Hu, Jianhong ^a,c   Yang, Yajie ^a   Turner, Peter C ^a   Jain, Vaibhav ^a   McIntyre, Lauren M ^a   Renne, Rolf ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE LYSINE METHYLTRANSFERASE; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; SETD1A PROTEIN, HUMAN; VIRUS ANTIGEN;

CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA RESPONSIVE ELEMENT; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; METABOLISM; METHYLATION; PLASMID;

ANTIGENS, VIRAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; EPIGENESIS, GENETIC; HEK293 CELLS; HERPESVIRUS 8, HUMAN; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; METHYLATION; NUCLEAR PROTEINS; PLASMIDS; RESPONSE ELEMENTS; SARCOMA, KAPOSI; TRANSCRIPTION, GENETIC;

EID: 84905405740     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004240     Document Type: Article

References (95)

1. Rivera CM, Ren B, (2013) Mapping human epigenomes. Cell 155: 39-55.
2. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, et al. (2007) High-resolution profiling of histone methylations in the human genome. Cell 129: 823-837.
3. Yu BD, Hess JL, Horning SE, Brown GA, Korsmeyer SJ, (1995) Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505-508.
4. Glaser S, Metcalf D, Wu L, Hart AH, DiRago L, et al. (2006) Enforced expression of the homeobox gene Mixl1 impairs hematopoietic differentiation and results in acute myeloid leukemia. Proc Natl Acad Sci U S A 103: 16460-16465.
5. Lubitz S, Glaser S, Schaft J, Stewart AF, Anastassiadis K, (2007) Increased apoptosis and skewed differentiation in mouse embryonic stem cells lacking the histone methyltransferase Mll2. Molecular biology of the cell 18: 2356-2366.
6. Dou Y, Milne TA, Ruthenburg AJ, Lee S, Lee JW, et al. (2006) Regulation of MLL1 H3K4 methyltransferase activity by its core components. Nat Struct Mol Biol 13: 713-719.
7. Steward MM, Lee JS, O'Donovan A, Wyatt M, Bernstein BE, et al. (2006) Molecular regulation of H3K4 trimethylation by ASH2L, a shared subunit of MLL complexes. Nat Struct Mol Biol 13: 852-854.
8. Demers C, Chaturvedi CP, Ranish JA, Juban G, Lai P, et al. (2007) Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. Molecular Cell 27: 573-584.
9. Rampalli S, Li L, Mak E, Ge K, Brand M, et al. (2007) p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 14: 1150-1156.
10. Li X, Wang S, Li Y, Deng C, Steiner LA, et al. (2011) Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 118: 1386-1394.
11. Tyagi S, Chabes AL, Wysocka J, Herr W, (2007) E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Molecular Cell 27: 107-119.
12. Knipe DM, Lieberman PM, Jung JU, McBride AA, Morris KV, et al. (2013) Snapshots: chromatin control of viral infection. Virology 435: 141-156.
13. Wysocka J, Myers MP, Laherty CD, Eisenman RN, Herr W, (2003) Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1. Genes & Development 17: 896-911.
14. Grundhoff A, Ganem D, (2004) Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. J Clin Invest 113: 124-136.
15. Dittmer DP, Damania B, (2013) Kaposi sarcoma associated herpesvirus pathogenesis (KSHV)-an update. Current opinion in virology 3: 238-244.
16. Speck SH, Ganem D, (2010) Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 8: 100-115.
17. Ballestas ME, Chatis PA, Kaye KM, (1999) Efficient persistence of extrachromosomal KSHV DNA mediated by latency- associated nuclear antigen. Science 284: 641-644.
18. Barbera AJ, Chodaparambil JV, Kelley-Clarke B, Joukov V, Walter JC, et al. (2006) The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science 311: 856-861.
19. Cotter MA 2nd, Robertson ES, (1999) The latency-associated nuclear antigen tethers the Kaposi's sarcoma- associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells [In Process Citation]. Virology 264: 254-264.
20. Garber AC, Hu J, Renne R, (2002) Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277: 27401-27411.
21. Hu J, Garber AC, Renne R, (2002) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells. J Virol 76: 11677-11687.
22. Kim KY, Huerta SB, Izumiya C, Wang DH, Martinez A, et al. (2013) Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen regulates the KSHV epigenome by association with the histone demethylase KDM3A. J Virol 87: 6782-6793.
23. Sakakibara S, Ueda K, Nishimura K, Do E, Ohsaki E, et al. (2004) Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen. J Virol 78: 7299-7310.
24. Krithivas A, Young DB, Liao G, Greene D, Hayward SD, (2000) Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 74: 9637-9645.
25. Lim C, Gwack Y, Hwang S, Kim S, Choe J, (2001) The transcriptional activity of cAMP response element-binding protein- binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 276: 31016-31022.
26. Jeong JH, Orvis J, Kim JW, McMurtrey CP, Renne R, et al. (2004) Regulation and autoregulation of the promoter for the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 279: 16822-16831.
27. Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, et al. (2006) Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest. J Virol 80: 10772-10786.
28. Platt GM, Simpson GR, Mittnacht S, Schulz TF, (1999) Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the drosophila female sterile homeotic (fsh) gene [In Process Citation]. J Virol 73: 9789-9795.
29. Viejo-Borbolla A, Ottinger M, Bruning E, Burger A, Konig R, et al. (2005) Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. J Virol 79: 13618-13629.
30. Lim C, Lee D, Seo T, Choi C, Choe J, (2003) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem 278: 7397-7405.
31. Shamay M, Krithivas A, Zhang J, Hayward SD, (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci U S A 103: 14554-14559.
32. Hu J, Liu E, Renne R, (2009) Involvement of SSRP1 in latent replication of Kaposi's sarcoma-associated herpesvirus. J Virol 83: 11051-11063.
33. Ballestas ME, Kaye KM, (2011) The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future microbiology 6: 1399-1413.
34. Gunther T, Grundhoff A, The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 6: e1000935.
35. Toth Z, Maglinte DT, Lee SH, Lee HR, Wong LY, et al. (2010) Epigenetic analysis of KSHV latent and lytic genomes. PLoS pathogens 6: e1001013.
36. Stedman W, Kang H, Lin S, Kissil JL, Bartolomei MS, et al. (2008) Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. Embo J 27: 654-666.
37. Tempera I, Lieberman PM, (2010) Chromatin organization of gammaherpesvirus latent genomes. Biochim Biophys Acta 1799: 236-245.
38. Langmead B, (2010) Aligning short sequencing reads with Bowtie. Curr Protoc Bioinformatics Chapter 11: Unit 11 17.
39. Bland JM, (1986) Computer simulation of a clinical trial as an aid to teaching the concept of statistical significance. Statistics in medicine 5: 193-197.
40. Bland JM, Altman DG, (1986) Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1: 307-310.
41. Dudoit S, Fridlyand J, (2002) A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biology 3doi:10.1186.
42. McIntyre LM, Lopiano KK, Morse AM, Amin V, Oberg AL, et al. (2011) RNA-seq: technical variability and sampling. BMC genomics 12: 293.
43. Ji H, Jiang H, Ma W, Johnson DS, Myers RM, et al. (2008) An integrated software system for analyzing ChIP-chip and ChIP-seq data. Nature biotechnology 26: 1293-1300.
44. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309-8315.
45. Pearce M, Matsumura S, Wilson AC, (2005) Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol 79: 14457-14464.
46. Cheng B, Li T, Rahl PB, Adamson TE, Loudas NB, et al. (2012) Functional association of Gdown1 with RNA polymerase II poised on human genes. Molecular cell 45: 38-50.
47. Feng W, Liu Y, Wu J, Nephew KP, Huang TH, et al. (2008) A Poisson mixture model to identify changes in RNA polymerase II binding quantity using high-throughput sequencing technology. BMC genomics 9 Suppl 2: S23.
48. Gu F, Hsu HK, Hsu PY, Wu J, Ma Y, et al. (2010) Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data. BMC systems biology 4: 170.
49. Darst RP, Haecker I, Pardo CE, Renne R, Kladde MP, (2013) Epigenetic diversity of Kaposi's sarcoma-associated herpesvirus. Nucleic Acids Res 41: 2993-3009.
50. Chandriani S, Ganem D, (2010) Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol 84: 5565-5573.
51. Toth Z, Brulois KF, Wong LY, Lee HR, Chung B, et al. (2012) Negative elongation factor-mediated suppression of RNA polymerase II elongation of Kaposi's sarcoma-associated herpesvirus lytic gene expression. J Virol 86: 9696-9707.
52. Chen W, Sin SH, Wen KW, Damania B, Dittmer DP, (2012) Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins. PLoS pathogens 8: e1003048.
53. An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, et al. (2006) Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo. J Virol 80: 4833-4846.
54. Lieberman PM, (2013) Keeping it quiet: chromatin control of gammaherpesvirus latency. Nature reviews Microbiology 11: 863-875.
55. Toth Z, Brulois K, Jung JU, (2013) The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 5: 1346-1373.
56. Hu J, Renne R, (2005) Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 79: 2637-2642.
57. Renne R, Barry C, Dittmer D, Compitello N, Brown PO, et al. (2001) Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75: 458-468.
58. Lu F, Tsai K, Chen HS, Wikramasinghe P, Davuluri RV, et al. (2012) Identification of host-chromosome binding sites and candidate gene targets for Kaposi's sarcoma-associated herpesvirus LANA. J Virol 86: 5752-5762.
59. Jeong J, Papin J, Dittmer D, (2001) Differential Regulation of the Overlapping Kaposi's Sarcoma-Associated Herpesvirus vGCR (orf74) and LANA (orf73) Promoters. J Virol 75: 1798-1807.
60. Kang H, Cho H, Sung GH, Lieberman PM, (2013) CTCF regulates Kaposi's sarcoma-associated herpesvirus latency transcription by nucleosome displacement and RNA polymerase programming. J Virol 87: 1789-1799.
61. Chen HS, Wikramasinghe P, Showe L, Lieberman PM, (2012) Cohesins repress Kaposi's sarcoma-associated herpesvirus immediate early gene transcription during latency. J Virol 86: 9454-9464.
62. Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, et al. (2005) Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 79: 7453-7465.
63. Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D, (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16: 1977-1989.
64. Rossetto C, Yamboliev I, Pari GS, (2009) Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis. J Virol 83: 8492-8501.
65. Ballestas ME, Kaye KM, (2001) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mediates episome persistence through cis-acting terminal repeat (TR) sequence and specifically binds TR DNA. J Virol 75: 3250-3258.
66. Tang J, Gordon GM, Muller MG, Dahiya M, Foreman KE, (2003) Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces expression of the helix-loop-helix protein Id-1 in human endothelial cells. J Virol 77: 5975-5984.
67. Lu J, Verma SC, Murakami M, Cai Q, Kumar P, et al. (2009) Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation. J Virol 83: 7129-7141.
68. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S, (2008) IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nature cell biology 10: 971-978.
69. Thomas-Chollier M, Darbo E, Herrmann C, Defrance M, Thieffry D, et al. (2012) A complete workflow for the analysis of full-size ChIP-seq (and similar) data sets using peak-motifs. Nature protocols 7: 1551-1568.
70. Thomas-Chollier M, Herrmann C, Defrance M, Sand O, Thieffry D, et al. (2012) RSAT peak-motifs: motif analysis in full-size ChIP-seq datasets. Nucleic Acids Res 40: e31.
71. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, et al. (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
72. Avalle L, Pensa S, Regis G, Novelli F, Poli V, (2012) STAT1 and STAT3 in tumorigenesis: A matter of balance. JAK-STAT 1: 65-72.
73. Jenner RG, Alba MM, Boshoff C, Kellam P, (2001) Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75: 891-902.
74. An FQ, Compitello N, Horwitz E, Sramkoski M, Knudsen ES, et al. (2005) The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus modulates cellular gene expression and protects lymphoid cells from p16 INK4A-induced cell cycle arrest. J Biol Chem 280: 3862-3874.
75. Toth Z, Brulois K, Lee HR, Izumiya Y, Tepper C, et al. (2013) Biphasic euchromatin-to-heterochromatin transition on the KSHV genome following de novo infection. PLoS pathogens 9: e1003813.
76. Hilton IB, Simon JM, Lieb JD, Davis IJ, Damania B, et al. (2013) The Open Chromatin Landscape of Kaposi's Sarcoma-Associated Herpesvirus. J Virol 87: 11831-11842.
77. Thomas-Chollier M, Defrance M, Medina-Rivera A, Sand O, Herrmann C, et al. (2011) RSAT 2011: regulatory sequence analysis tools. Nucleic Acids Res 39: W86-91.
78. Kelley-Clarke B, De Leon-Vazquez E, Slain K, Barbera AJ, Kaye KM, (2009) Role of Kaposi's sarcoma-associated herpesvirus C-terminal LANA chromosome binding in episome persistence. J Virol 83: 4326-4337.
79. Vazquez Ede L, Carey VJ, Kaye KM, (2013) Identification of Kaposi's sarcoma-associated herpesvirus LANA regions important for episome segregation, replication, and persistence. J Virol 87: 12270-12283.
80. Wong LY, Matchett GA, Wilson AC, (2004) Transcriptional activation by the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen is facilitated by an N-terminal chromatin-binding motif. J Virol 78: 10074-10085.
81. Mercier A, Arias C, Madrid AS, Holdorf MM, Ganem D, (2014) Site-specific association with host and viral chromatin by KSHV LANA and its reversal during lytic replication. Journal of Virology doi: 10.1128.
82. Chang HH, Ganem D, (2013) A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host & Microbe 13: 429-440.
83. Yuan W, Wu T, Fu H, Dai C, Wu H, et al. (2012) Dense chromatin activates Polycomb repressive complex 2 to regulate H3 lysine 27 methylation. Science 337: 971-975.
84. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, et al. (2004) Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol 78: 3601-3620.
85. Kang H, Wiedmer A, Yuan Y, Robertson E, Lieberman PM, (2011) Coordination of KSHV latent and lytic gene control by CTCF-cohesin mediated chromosome conformation. PLoS Pathogens 7: e1002140.
86. Langmead B, Trapnell C, Pop M, Salzberg SL, (2009) Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25.
87. Edgar R, Domrachev M, Lash AE, (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
88. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B, (2008) Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621-628.
89. Bland JM, Altman DG, (1988) Misleading statistics: errors in textbooks, software and manuals. International Journal of Epidemiology 17: 245-247.
90. Bland JM, Altman DJ, (1986) Regression analysis. Lancet 1: 908-909.
91. Landt SG, Marinov GK, Kundaje A, Kheradpour P, Pauli F, et al. (2012) ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 22: 1813-1831.
92. Rice P, Longden I, Bleasby A, (2000) EMBOSS: the European Molecular Biology Open Software Suite. Trends in Genetics: TIG 16: 276-277.
93. Quinlan AR, Hall IM, (2010) BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841-842.
94. Ye T, Krebs AR, Choukrallah MA, Keime C, Plewniak F, et al. (2011) seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res 39: e35.
95. Li Y, Deng C, Hu X, Patel B, Fu X, et al. (2012) Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis. Oncogene 31: 5007-5018.